Literature DB >> 33429750

The efficacy of bosentan combined with vardenafil in the treatment of postoperative pulmonary hypertension in children with congenital heart disease: A protocol of randomized controlled trial.

Chao Gao1, Junting Liu, Runhan Zhang, Manting Zhao, Yongli Wu.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33429750      PMCID: PMC7793405          DOI: 10.1097/MD.0000000000023896

Source DB:  PubMed          Journal:  Medicine (Baltimore)        ISSN: 0025-7974            Impact factor:   1.817


× No keyword cloud information.
  14 in total

1.  Medical therapy for pulmonary arterial hypertension: updated ACCP evidence-based clinical practice guidelines.

Authors:  David B Badesch; Steven H Abman; Gerald Simonneau; Lewis J Rubin; Vallerie V McLaughlin
Journal:  Chest       Date:  2007-06       Impact factor: 9.410

2.  Treatment of secondary pulmonary hypertension with bosentan after left ventricular assist device implantation.

Authors:  Shane J LaRue; Rafael Garcia-Cortes; Michael E Nassif; Justin M Vader; Shuddhadeb Ray; Ashwin Ravichandran; Ravi Rasalingham; Scott C Silvestry; Gregory A Ewald; I-Wen Wang; Joel D Schilling
Journal:  Cardiovasc Ther       Date:  2015-04       Impact factor: 3.023

3.  Pulmonary hypertension associated with congenital heart disease: pulmonary vascular disease: the global perspective.

Authors:  Ian Adatia; Shyam S Kothari; Jeffrey A Feinstein
Journal:  Chest       Date:  2010-06       Impact factor: 9.410

Review 4.  Anticoagulation in Pulmonary Arterial Hypertension.

Authors:  Jeffrey C Robinson; Steven C Pugliese; Daniel L Fox; David B Badesch
Journal:  Curr Hypertens Rep       Date:  2016-06       Impact factor: 5.369

Review 5.  [Pulmonary arterial hypertension: modern diagnostics and therapy--Part 1].

Authors:  Katarzyna Betkier-Lipińska; Robert Ryczek; Przemysław Kwasiborski; Andrzej Cwetsch
Journal:  Pol Merkur Lekarski       Date:  2013-06

6.  Bosentan-sildenafil association in patients with congenital heart disease-related pulmonary arterial hypertension and Eisenmenger physiology.

Authors:  Michele D'Alto; Emanuele Romeo; Paola Argiento; Berardo Sarubbi; Giuseppe Santoro; Nicola Grimaldi; Anna Correra; Giancarlo Scognamiglio; Maria Giovanna Russo; Raffaele Calabrò
Journal:  Int J Cardiol       Date:  2010-11-16       Impact factor: 4.164

7.  The regulation of transient receptor potential canonical 4 (TRPC4) channel by phosphodiesterase 5 inhibitor via the cyclic guanosine 3'5'-monophosphate.

Authors:  Jinhong Wie; SeungJoo Jeong; Misun Kwak; Jongyun Myeong; MeeRee Chae; Jong Kwan Park; Sung Won Lee; Insuk So
Journal:  Pflugers Arch       Date:  2017-01-26       Impact factor: 3.657

8.  2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT).

Authors:  Nazzareno Galiè; Marc Humbert; Jean-Luc Vachiery; Simon Gibbs; Irene Lang; Adam Torbicki; Gérald Simonneau; Andrew Peacock; Anton Vonk Noordegraaf; Maurice Beghetti; Ardeschir Ghofrani; Miguel Angel Gomez Sanchez; Georg Hansmann; Walter Klepetko; Patrizio Lancellotti; Marco Matucci; Theresa McDonagh; Luc A Pierard; Pedro T Trindade; Maurizio Zompatori; Marius Hoeper
Journal:  Eur Heart J       Date:  2015-08-29       Impact factor: 29.983

Review 9.  Recognition and management of arrhythmias in adult congenital heart disease.

Authors:  Christopher J McLeod; Carole Warnes
Journal:  Curr Opin Cardiol       Date:  2016-01       Impact factor: 2.161

10.  Erratum to: Tachyarrhythmia in patients with congenital heart disease: inevitable destiny.

Authors:  C P Teuwen; Y J H J Taverne; C Houck; M Götte; B J J M Brundel; R Evertz; M Witsenburg; J W Roos-Hesselink; A J J C Bogers; N M S de Groot
Journal:  Neth Heart J       Date:  2016-04       Impact factor: 2.380

View more
  1 in total

Review 1.  Congenital Heart Disease: The State-of-the-Art on Its Pharmacological Therapeutics.

Authors:  Carlos Daniel Varela-Chinchilla; Daniela Edith Sánchez-Mejía; Plinio A Trinidad-Calderón
Journal:  J Cardiovasc Dev Dis       Date:  2022-06-26
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.